Max Healthcare Institute (543220) Q4 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 25/26 earnings summary
8 Jul, 2026Executive summary
Phased commissioning of over 20% additional brownfield capacity across Mohali, Nanavati (Mumbai), and Max Smart (Delhi) in the last two quarters, with all beds to be operational in the next 2-3 months; another 10% capacity expected from Gurugram later in 2026.
Acquisition of a controlling 58.28% stake in Kalinga Hospital (Bhubaneswar) completed in May 2026, marking entry into Eastern India and providing a platform for future expansion.
Board approved INR 1,400 crore investment for a new 700-712 bed greenfield hospital at Shaheed Path, Lucknow, to be commissioned by FY30.
22nd consecutive quarter of year-on-year growth, with FY26 gross revenue up 16% YoY to INR 10,538 crore, operating EBITDA up 14% YoY to INR 2,638 crore, and PAT after exceptional items up 22% YoY to INR 1,631 crore.
Final dividend of ₹2 per equity share recommended, subject to shareholder approval.
Financial highlights
Q4 FY26 gross revenue: INR 2,664 crore (+10% YoY, +2% QoQ); operating EBITDA: INR 682 crore (+8% YoY, +5% QoQ); EBITDA margin: 26.8%.
FY26 gross revenue: INR 10,538 crore (+16% YoY); operating EBITDA: INR 2,638 crore (+14% YoY); EBITDA margin: 26.2%.
Q4 profit after tax: INR 387 crore, up from INR 376 crore YoY and INR 344 crore QoQ.
Free cash flow in Q4: INR 581 crore; net debt at FY26 end: INR 1,908 crore (net debt/EBITDA < 1); cash from operations: INR 1,541 crore.
Pre-tax ROCE: 20.9% in Q4 FY26 (vs 23.8% Q4 FY25); 21.8% in FY26 (vs 25.9% FY25).
Outlook and guidance
Focus on scaling newly commissioned capacities, integrating Kalinga Hospital, and progressing expansion projects including Sector 56 Gurgaon and Lucknow.
500-bed Gurgaon hospital to be commissioned by end of FY27, with phased operationalization starting at ~200 beds; 712-bed Lucknow hospital expected by FY30.
Additional brownfield/asset-light expansions planned in Pune, Dwarka, Dehradun, and other locations.
Expect operating leverage as new beds ramp up occupancy; no major regulatory delays anticipated for upcoming projects.
Latest events from Max Healthcare Institute
- Q2 FY26 delivered 21% revenue and 23% EBITDA growth, driven by expansion and digital gains.543220
Q2 25/268 Jul 2026 - FY25 revenue rose 26% YoY to INR 9,065 Cr, with robust EBITDA growth and major expansions.543220
Q4 24/258 Jul 2026 - Q1 FY25 saw 18% revenue growth, high occupancy, and strong expansion momentum.543220
Q1 24/258 Jul 2026 - Q3 FY25 revenue rose 34% with strong EBITDA, major expansions, and Jaypee Healthcare acquisition.543220
Q3 24/258 Jul 2026 - Q3 FY26 delivered strong growth, with expansion, digital gains, and regulatory impacts shaping outlook.543220
Q3 25/2612 Apr 2026 - Strong revenue and EBITDA growth, major acquisitions, and expansion marked the quarter.543220
Q2 24/2516 Jan 2026 - Revenue up 27% YoY, EBITDA up 23%, and PAT up 17% amid robust expansion and digital growth.543220
Q1 25/2623 Nov 2025